World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
22011
World Ranking
2556
National Ranking
8

Overview

Lisa F. P. Ng is affiliated with the Agency for Science, Technology and Research in Singapore. Their research is primarily situated within the field of medicine, with a focus on infectious diseases, immunology, public health, environmental and occupational health, neurology, and epidemiology.

Their work extensively covers several main topics including SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, the long-term effects of COVID-19, mosquito-borne diseases and control, SARS-CoV-2 detection and testing, animal virus infections studies, and viral infections and vectors.

Frequent publication venues for their research include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Frontiers in Immunology
  • Clinical & Translational Immunology
  • Nature Communications

They have collaborated regularly with several co-authors, including:

  • Laurent Rénia (115 publications)
  • David Chien Lye (72 publications)
  • Barnaby Edward Young (69 publications)
  • Siew-Wai Fong (64 publications)
  • Yee-Sin Leo (50 publications)

Their recent papers include:

  • "The trinity of COVID-19: immunity, inflammation and intervention," 2020, Nature Reviews Immunology
  • "Immunity, endothelial injury and complement-induced coagulopathy in COVID-19," 2020, Nature Reviews Nephrology
  • "Advances in targeted therapy for esophageal cancer," 2020, Signal Transduction and Targeted Therapy
  • "Monkeypox: disease epidemiology, host immunity and clinical interventions," 2022, Nature Reviews Immunology
  • "Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study," 2020, The Lancet

Best Publications

  • The trinity of COVID-19: immunity, inflammation and intervention.

    Matthew Zirui Tay;Chek Meng Poh;Laurent Rénia;Laurent Rénia;Paul A MacAry

  • Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

    Yijun Ruan;Chia Lin Wei;Ai Ee Ling;Vinsensius B Vega

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.

    Luca Perico;Ariela Benigni;Federica Casiraghi;Lisa F.P. Ng;Lisa F.P. Ng

  • Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen

    Felicity J Burt;Weiqiang Chen;Jonathan J Miner;Deborah J Lenschow

  • Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.

    Chek Meng Poh;Guillaume Carissimo;Bei Wang;Siti Naqiah Amrun

  • Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.

    Barnaby E Young;Barnaby E Young;Siew-Wai Fong;Siew-Wai Fong;Yi-Hao Chan;Tze-Minn Mak

  • Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor

    Angela Chow;Zhisheng Her;Zhisheng Her;Edward K S Ong;Jin-miao Chen

  • Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.

    Wan Ni Chia;Feng Zhu;Sean Wei Xiang Ong;Barnaby Edward Young;Barnaby Edward Young

  • IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

    Lisa F. P. Ng;Angela Chow;Yong-Jiang Sun;Dyan J. C. Kwek

  • Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response

    Zhisheng Her;Benoit Malleret;Monica Chan;Edward K. S. Ong

  • Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.

    Cheryl Yi Pin Lee;Raymond T.P. Lin;Laurent Renia;Laurent Renia;Lisa F.P. Ng;Lisa F.P. Ng;Lisa F.P. Ng

  • Catching bird flu in a droplet.

    Juergen Pipper;Masafumi Inoue;Lisa F.-P. Ng;Pavel Neuzil

  • A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice

    Teck-Hui Teo;Teck-Hui Teo;Fok-Moon Lum;Fok-Moon Lum;Carla Claser;Valeria Lulla

  • Chikungunya fever

    Unknown

  • Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein

    Yiu‐Wing Kam;Fok‐Moon Lum;Fok‐Moon Lum;Teck‐Hui Teo;Wendy W. L. Lee

  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.

    Jean-Laurent Casanova;Helen C. Su;Covid Human Genetic Effort

  • Viperin restricts chikungunya virus replication and pathology

    Terk-Shin Teng;Suan Sin Foo;Diane Simamarta;Fok-Moon Lum

  • Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.

    Barnaby E Young;Barnaby E Young;Sean W X Ong;Lisa F P Ng;Danielle E Anderson

  • Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection

    Yiu-Wing Kam;Diane Simarmata;Angela Chow;Zhisheng Her;Zhisheng Her

  • Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro

    Yiu-Wing Kam;Yuushi Okumura;Hiroshi Kido;Lisa F. P. Ng;Lisa F. P. Ng

Frequent Co-Authors

Laurent Rénia
Laurent Rénia Nanyang Technological University
Yee Sin Leo
Yee Sin Leo Nanyang Technological University
Barnaby Young
Barnaby Young National Centre for Infectious Diseases
David C. Lye
David C. Lye Tan Tock Seng Hospital
Julian A. Hiscox
Julian A. Hiscox University of Liverpool
Raymond T. P. Lin
Raymond T. P. Lin National University of Singapore
Paul A. Tambyah
Paul A. Tambyah National University of Singapore
Andres Merits
Andres Merits University of Tartu
Olaf Rötzschke
Olaf Rötzschke Agency for Science, Technology and Research
Marc Lecuit
Marc Lecuit Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various related healthcare careers. Many students interested in immunology often consider accelerated nursing pathways to quickly enter patient-focused roles. Programs such as accelerated nurse practitioner programs provide a faster route to advanced clinical positions, blending immunology knowledge with direct patient care.

For those new to healthcare, there are specialized options like the 12-month accelerated nursing programs online for non nurses which allow non-nursing graduates to swiftly transition into nursing roles. These programs emphasize foundational nursing skills alongside biological sciences, including immunology concepts.

Entry into nursing can also be made simpler through the easiest accelerated nursing programs, designed to accommodate a wide range of applicants while maintaining quality education. Similarly, which lpn programs are easiest to get into can be excellent starting points for those seeking licensed practical nurse qualifications with a shorter commitment, often incorporating immunology fundamentals relevant to patient care.

Understanding these options can help immunology students align their educational choices with career goals that emphasize applied healthcare and clinical expertise.

Best Scientists Citing Lisa F. P. Ng

Trending Scientists

Recently Published Articles